IP Review

This fragment is not visible to the reader

This publication includes IP covered under the following statements.

The UCUM codes, UCUM table (regardless of format), and UCUM Specification are copyright 1999-2009, Regenstrief Institute, Inc. and the Unified Codes for Units of Measures (UCUM) Organization. All rights reserved. https://ucum.org/trac/wiki/TermsOfUse
Show Usage
- Unified Code for Units of Measure (UCUM) : DosageDE , DosageDoseQuantityDEVS , DurationUnitsOfTimeDgMPVS , PeriodUnitsOfTimeDgMPVS and TimingDgMP
Unless otherwise indicated, reproduction of material posted on Council of Europe websites, and reproduction of photographs for which the Council of Europe holds copyright – see legal notice \“photo credits\” – is authorised for private use and for informational and educational uses relating to the Council of Europe’s work. This authorisation is subject to the condition that the source be indicated and no charge made for reproduction. Persons wishing to make some other use than those specified above, including commercial use, of information and text posted on these sites are asked to apply for prior written authorisation to the Council of Europe, Directorate of Communication.
Show Usage
- EDQM Standard Terms : EDQMUnitOfPresentationVS

hl7.fhir.us.hai: Healthcare Associated Infection Implementation Guide ®© HL7 | CC0 ( src )

Dieser Implementation Guide (IG) beschreibt die standardisierte und interoperable Abbildung medikationsbezogener Informationen und Prozesse im deutschen Gesundheitswesen auf Basis von HL7® FHIR®. Ziel ist es, sektorenübergreifende Anwendungsfälle – wie beispielsweise die strukturierte Dosierungsinformation im E-Rezept oder den elektronischen Medikationsplan – zu ermöglichen und zu harmonisieren. ( src )

HL7®, HEALTH LEVEL SEVEN®, FHIR® und das FHIR®-Logo sind Marken von Health Level Seven International, eingetragen beim United States Patent and Trademark Office. ( src )

There are examples where a medication request may include the option of an oral dose or an Intravenous or Intramuscular dose. For example, "Ondansetron 8mg orally or IV twice a day as needed for nausea" or "Compazine® (prochlorperazine) 5-10mg PO or 25mg PR bid prn nausea or vomiting". In these cases, two medication requests would be created that could be grouped together. The decision on which dose and route of administration to use is based on the patient's condition at the time the dose is needed. ( src )

External References

Unattributed Code Systems

Copyright Fragment

Copyright and Registered Trademark Uses

External References

Internal Images